NEUROSANTE B.V. is dedicated to transforming healthcare through advanced medical technology and innovation. The company is a leading provider of the NeuroCes™ Cranial Electrotherapy Stimulator in Europe, aiming to improve well-being through safe, effective medical solutions developed in collaboration with healthcare professionals.

​

The company’s objectives are:

• developing producing and selling electrotherapy stimulation devices and everything related to this, both national and international;

• researching new technologies and developing (electromedical) related devices;

• the marketing and distribution of electrotherapy stimulation devices and all related devices;

• to engage in holding, administration and management activities;

• to incorporate, acquire, participate in, collaborate with, conduct the management of, and finance, or have others finance, other businesses, whatever their legal form;

• to provide commercial, financial and/or economic and legal advice, as well as to perform all other work in the field of organisation and consultancy, as well as to render services and give advice in the field of management and furnish interim management and project management, or cause such to be furnished, all in the broadest sense;

• to invest capital in shares, securities, registered property, debts, funds and other asset values, as well as to acquire, alienate, operate and manage these objects of investment or rights to such;

• to exploit, obtain and dispose of goods (items and property rights), expressly including patents, licences, know-how and trademarks; to rent and lease, purchase and sell, as well as to trade in property and registered property;

• to provide loans and enter into loan agreements, manage and hold registered property and make security available, including for third-party debts;

• to undertake everything that is related or may be conducive to the above, all in the broadest sense.